Knudra Diagnostics

Knudra Diagnostics, located in Salt Lake City, UT, is at the forefront of developing innovative solutions for combating drug resistance in anthelmintic treatments. Their focus lies in creating a novel platform utilizing genetically engineered nematodes, specifically Celegans, to discover new antiparasitic drugs that can effectively address the growing challenges in livestock and human health.

The company's research aims to generate a new class of anthelmintics by targeting specific parasite genes, ultimately providing a rapid pathway for drug discovery. With the potential to access a market valued at over $1.5 billion per year, Knudra Diagnostics is poised to make significant contributions to the field of parasitology and agricultural sustainability.

Generated from the website